Akili, Inc.
AKLI
$0.4088
$0.01634.15%
Headlines
4/30/2024
-
InvestorPlace
4/30/2024
-
InvestorPlace
4/30/2024
-
Business Wire
4/27/2024
-
Ticker Report
4/13/2024
-
Ticker Report
3/11/2024
-
Bizjournals.com - Health Care News
3/3/2024
-
Zolmax
3/1/2024
-
TipRanks Financial Blog
2/29/2024
-
Business Wire
2/27/2024
-
Business Wire
2/26/2024
-
InvestorPlace
2/26/2024
-
Seeking Alpha - Healthcare
2/26/2024
-
SeekingAlpha.com: All News
2/26/2024
-
The Fly
2/26/2024
-
Business Wire
2/21/2024
-
TipRanks Financial Blog
2/21/2024
-
Business Wire
2/15/2024
-
Zolmax
1/30/2024
-
Zolmax
1/15/2024
-
Zacks Investment Research
12/30/2023
-
Zolmax
12/27/2023
-
Zolmax
12/21/2023
-
Zacks Investment Research
12/19/2023
-
TipRanks Financial Blog
Filings
Thursday, February 29, 2024
Sunday, December 31, 2023
Week of May 6 and 10 (est)
Price History
--
--
Corporate Info
617 313 8853
No. 312, 71 Commercial Street
Boston, MA 02109
Boston, MA 02109
Business Description
Akili, Inc., a digital medicine company, develops cognitive treatments through game-changing technologies. The company provides EndeavorRx, a computer-based testing for cognitive dysfunction...
more